CTRI/2021/07/034552CompletedPhase 2
evetiracetam versus valproate as second line antiepileptic for management of status epilepticus in chidren.
Pandit BDSharma UHSRPGIMS ROHTAK0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Children aged 3 years to 14 years with convulsive status epilepticus (clonic, tonic, tonic clonic, focal or generalised) who are neurologically normal prior to current illness will be enrolled.
Exclusion Criteria
- •Acute or chronic liver disease or kidney disease.
- •Children with global developmental delay or intellectual disability.
- •Severe protein energy malnutrition.
- •Patients who have received the study drug prior to presentation in emergency department
Investigators
Similar Trials
Recruiting
Phase 4
Comparison of levetiracetam and phenytoin in newborns with refractory seizuresCTRI/2024/02/062227All India Institute of Medical Sciences, Rishikesh
Completed
Not Applicable
A study comparing Levetiracetam and Valproic Acid in preventing seizure in children diagnosed with neurocystcercosis.CTRI/2019/01/017368Dr Abhinav Aggarwal50
Recruiting
Phase 3
Efficacy of Levetiracetam In pedatrics migrain headacheMigraineIRCT20160802029171N3Hamedan University of Medical Sciences39
Not yet recruiting
Phase 3
A clinical trial to study the effectiveness of Perampanel compared to Levetiracetam as first line anti-seizure drug in adult patients with new onset focal seizuresCTRI/2024/03/064453AIIMS Bhubaneswar
Completed
Phase 2
Effect of levetiracetam and sodium valproate versus sodium valproate alone on epileptiform discharges in electroencephalogram in interictal phase in children with epilepsyEpilepsy.Epilepsy and recurrent seizuresIRCT20120215009014N246Hamedan University of Medical Sciences42